Thyroglobulin

Iodination adds iodine to selected tyrosine residues within thyroglobulin, creating modified residues that can participate in coupling reactions. These reactions join the iodinated components to form thyroxine (T4) and triiodothyronine (T3) while they remain associated with the protein. This arrangement links hormone synthesis to a protein-based storage framework inside thyroid follicles.

Tyrosine residues provide the sites that receive iodine during hormone production. Their modification creates the chemical intermediates required for subsequent coupling, so the protein is not merely a storage scaffold. The location of these reactions within thyroglobulin allows T3 and T4 to form in the follicular colloid before thyroid cells later retrieve the protein.

Follicular colloid provides the compartment into which thyroglobulin is secreted and where iodination and coupling occur. It therefore supports both the assembly and temporary retention of thyroid hormones within the protein. By concentrating this sequence outside the follicular cell interior, the colloid connects secretion of the precursor with later hormone recovery.

Thyroid follicular cells retrieve thyroglobulin from the colloid and direct it to lysosomes, cellular compartments that degrade proteins. Lysosomal breakdown separates the completed hormones from their protein framework, allowing T3 and T4 to leave the thyroid cell and enter the bloodstream. This retrieval-and-degradation step converts stored hormone into a releasable form.

A useful sequence follows thyroglobulin secretion into the follicular colloid, iodination of its tyrosine residues, coupling to generate T3 and T4, and later cellular retrieval with lysosomal degradation. Examining these stages separately helps connect molecular modification, intracellular trafficking, protein breakdown, and hormone release within one thyroid-centered pathway.

Serum thyroglobulin serves as a biomarker in monitoring differentiated thyroid cancer after treatment. Its measurement provides clinically relevant information about the presence or activity of thyroid-derived tissue in the post-treatment setting. In this context, thyroglobulin is used not to describe hormone synthesis alone, but to support follow-up assessment of disease status.